Taché Y - Search Results

1

CRF1 receptors as a therapeutic target for irritable bowel syndrome.

Martinez V, Taché Y. Martinez V, et al. Among authors: tache y. Curr Pharm Des. 2006;12(31):4071-88. doi: 10.2174/138161206778743637. Curr Pharm Des. 2006. PMID: 17100612 Review.

2

CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome.

Taché Y, Martinez V, Wang L, Million M. Taché Y, et al. Br J Pharmacol. 2004 Apr;141(8):1321-30. doi: 10.1038/sj.bjp.0705760. Br J Pharmacol. 2004. PMID: 15100165 Free PMC article. Review.

3

Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice.

Martínez V, Wang L, Rivier J, Grigoriadis D, Taché Y. Martínez V, et al. Among authors: tache y. J Physiol. 2004 Apr 1;556(Pt 1):221-34. doi: 10.1113/jphysiol.2003.059659. Epub 2004 Jan 30. J Physiol. 2004. PMID: 14755002 Free PMC article.

4

Urocortins and the regulation of gastrointestinal motor function and visceral pain.

Martinez V, Wang L, Million M, Rivier J, Taché Y. Martinez V, et al. Among authors: tache y. Peptides. 2004 Oct;25(10):1733-44. doi: 10.1016/j.peptides.2004.05.025. Peptides. 2004. PMID: 15476940 Review.

5

Role of corticotropin releasing factor receptor subtype 1 in stress-related functional colonic alterations: implications in irritable bowel syndrome.

Taché Y, Martinez V, Million M, Maillot C. Taché Y, et al. Eur J Surg Suppl. 2002;(587):16-22. Eur J Surg Suppl. 2002. PMID: 16144197 Review.

6

Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function.

Martínez V, Rivier J, Wang L, Taché Y. Martínez V, et al. Among authors: tache y. J Pharmacol Exp Ther. 1997 Feb;280(2):754-60. J Pharmacol Exp Ther. 1997. PMID: 9023288

7

Central CRF inhibits gastric emptying of a nutrient solid meal in rats: the role of CRF2 receptors.

Martinez V, Barquist E, Rivier J, Taché Y. Martinez V, et al. Among authors: tache y. Am J Physiol. 1998 May;274(5):G965-70. doi: 10.1152/ajpgi.1998.274.5.G965. Am J Physiol. 1998. PMID: 9612279

8

Peripheral urocortin delays gastric emptying: role of CRF receptor 2.

Nozu T, Martinez V, Rivier J, Taché Y. Nozu T, et al. Among authors: tache y. Am J Physiol. 1999 Apr;276(4):G867-74. doi: 10.1152/ajpgi.1999.276.4.G867. Am J Physiol. 1999. PMID: 10198329

9

Corticotropin-releasing factor and the brain-gut motor response to stress.

Taché Y, Martinez V, Million M, Rivier J. Taché Y, et al. Can J Gastroenterol. 1999 Mar;13 Suppl A:18A-25A. doi: 10.1155/1999/375916. Can J Gastroenterol. 1999. PMID: 10202204 Review.

10

Peripheral injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks peripheral CRF- and abdominal surgery-induced delayed gastric emptying in rats.

Martínez V, Rivier J, Taché Y. Martínez V, et al. Among authors: tache y. J Pharmacol Exp Ther. 1999 Aug;290(2):629-34. J Pharmacol Exp Ther. 1999. PMID: 10411571

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

495 results

Search Page

Filters